Argun Kurum, GamzeKaya Dağıstanlı, FatmaÖztürk, Melek2024-07-122024-07-122019Argun Kurum, G., Kaya Dağıstanlı, F. ve Öztürk, M. (2014). Vildalgiptin as a dipeptidyl peptidase-4 inhibitor treatment in STZ-diabetic newborn rats. Frontiers in Medical Sciences: Diabetes, Cancer and Their Connection / Tıpta Yenilikler: Diyabet, Kanser ve İlişkileri, Maltepe Üniversitesi. s. 85.https://hdl.handle.net/20.500.12415/3359Type 2 diabetes mellitus is a complex and progressive disease. New treatment strategies including enhances and prolongs the action of the endogenous incretin hormones. Inhibition of the enzyme dipeptidyl peptidase-4 (DPP-4) slows degradation of endogenous glucagon-like peptide-1 (GLP-1).enCC0 1.0 Universalinfo:eu-repo/semantics/openAccessExprimental diabetesSTZ-diabetic newborn ratsDPP4 inhibitorVildagliptinConference Object8685